Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,728 total articles
Universal Technical Institute Chief Executive Officer Jerome Alan Grant sold 60,040 shares of the company's common stock on February 27, 2026, for roughly $2.10 million. The transaction occurred as UTI shares traded close to their 52-week high and follows mixed first-quarter fiscal 2026 results that included a slight EPS miss but a revenue beat. An…
M&T Bank Corp Senior Executive Vice President Michael A. Wisler sold 8,236.977 shares of common stock on February 26, 2026, for $1,840,809 and exercised options to acquire 4,751 shares with a total exercise value of $702,438. The transactions occurred amid the bank’s fourth-quarter earnings beat, a declared quarterly dividend and a regional leaders…
Fluor Corp Chief Financial Officer John C. Regan sold $1,504,061 of company stock on February 26 and 27, 2026, after exercising options to acquire 16,773 shares at $17.96. The transactions, disclosed on a Form 4 filing, were executed in multiple tranches at prices ranging roughly between $50.96 and $53.32. After the sales Regan retains 103,859 shar…
IDEAYA Biosciences director Jeffrey Stein purchased 50,000 common shares on March 2, 2026, investing $1.65 million. The transaction leaves Stein with 54,281 shares directly and an additional 3,363 shares held indirectly by his son. The insider buy comes as IDEAYA trades near its assessed fair value and as the company reports clinical and leadership…
Interactive Communications International, Inc. reported a sale of 17,610 shares of Giftify, Inc. (NASDAQ: GIFT) on February 26, 2026, at a weighted average price of $0.934 for a total of $16,447. The trade reduced the company's position but left it with 2,577,760 shares. The transaction was also reported by HI Technology Corp and Merrill Brooks Smi…
Dakota Gold (NYSE: DC) Vice President of Exploration James McCoy Berry sold 12,388 shares on February 27, 2026, to meet tax obligations tied to the vesting of performance share units. The sale occurred near the stock's 52-week high, while Berry simultaneously converted multiple tranches of PSUs into common shares and exercised a large block of opti…
InfuSystem Holdings' Executive Vice President and CFO Barry G. Steele purchased 2,064 shares on March 2, 2026, at $9.16 per share, a $18,906 investment that followed a subsequent rise in the stock to $9.29. The insider transaction brings Steele's direct holdings to 88,000 shares. Separately, the company posted fourth-quarter 2025 earnings that beat…
Michael A. Plater, a director at Lincoln Educational Services (LINC), sold 17,256 shares on March 2, 2026, for about $616,556 in multiple open-market transactions. The company reported fourth-quarter 2025 revenue of $142.9 million, beating a $132.8 million forecast, and EPS of $0.40, in line with expectations. Following the sale, Plater directly ho…
Oruka Therapeutics Chief Operating Officer Laura Lee Sandler sold 5,000 shares of company stock on March 2, 2026, generating $167,821 in proceeds across two trades, and concurrently exercised employee warrants to acquire 5,000 additional shares for $39,000. The transactions occurred under a pre-arranged Rule 10b5-1 plan and follow a period of subst…
LifeVantage Corp director Dayton Judd purchased 33,197 shares across three transactions between February 26 and March 2, 2026, spending $152,422. The purchases, disclosed on a Form 4 filing with the SEC, leave Judd with 80,359 directly owned shares and 749,325 indirectly held through Sudbury Capital Fund, LP. The trades arrive amid a fiscal Q2 repo…
Contineum Therapeutics Chief Scientific Officer Lorrain Daniel S. sold 4,170 shares of Class A common stock on March 2, 2026, under a pre-arranged 10b5-1 trading plan. The transaction occurred as the company's shares traded near a 52-week high and following clinical trial results that prompted an analyst downgrade. Separately, Contineum priced an u…
Contineum Therapeutics' Chief Medical Officer and Head of Development, Tim Watkins, sold 3,611 Class A shares on March 2, 2026, at a weighted average price of $15.0153 and simultaneously exercised 3,611 options at $4.50. The company announced an upsized public offering priced at $12.25 per share and faces a recent analyst downgrade following mixed …
Daniel Breeze, senior vice president of corporate development at Royal Gold Inc., disposed of 1,400 shares of the company on March 2, 2026, realizing roughly $421,211 across two trades. The sale occurred while Royal Gold shares hovered close to a 52-week peak, following material restricted stock unit vesting earlier in the week. The company reporte…
Boyd Gaming CFO and Treasurer Josh Hirsberg sold 23,924 shares on February 26, 2026 for $2,054,114 after exercising an equal number of employee stock options at $17.75 each. The transaction leaves Hirsberg with substantial direct and indirect holdings while Boyd reports robust Q4 2025 results, a recent asset sale, and an executive retirement announ…
Hercules Capital Chief Financial Officer Seth H Meyer acquired 14,000 shares of common stock on February 27, 2026, in a transaction valued at $200,620. The purchase occurred as HTGC shares have fallen over the past year and amid mixed company developments including a modest rise in estimated NAV per share, a loan amendment tied to potential FDA app…
A Form 4 filing shows director Hatcher Robert V. III sold 150 shares of Kinsale Capital Group, Inc. (NASDAQ:KNSL) on February 26, 2026, at $379.68 per share for a total of $56,952. The insurer's stock is trading above that sale price, and the firm recently reported quarterly results that exceeded analyst estimates even as a major bank cut its price…
eHealth CEO Derrick A. Duke purchased 187,969 shares on February 27, 2026, at $1.38 per share, totaling $259,397, according to a Form 4 filing. The transaction raises Duke's direct holdings to 487,969 shares as the stock trades near a 52-week low amid a recent earnings period marked by a revenue beat and an EPS shortfall.
Hasbro Chief Executive Christian P. Cocks sold 196,411 shares of Hasbro stock on February 26, 2026, for $19.7 million, while exercising options to acquire the same number of shares at $55.78 the same day. The moves occur as Hasbro shares trade close to a 52-week high following strong gains over the past year, and after a quarter that drew bullish r…
SoFi Technologies Chief Executive Anthony Noto purchased 56,000 shares on March 2, 2026, investing $1,001,515 at prices between $17.500 and $18.205. The buy raises his direct holdings to 11,675,452 shares and was executed across multiple trades at a weighted average price of $17.8842. The trade comes while the stock has fallen 32% year-to-date and …
Director Alejandro M. Sanchez sold 1,044 shares of Republic Bancorp Class A common stock on February 26, 2026, for $71.04 per share, netting about $74,165 and leaving him with no direct holdings. The bank's stock trades at $70.03 with a P/E of 10.53 and InvestingPro flags the stock as undervalued versus Fair Value. Republic Bancorp also announced a…
Standex International director Thomas E. Chorman sold 513 shares of common stock on February 27, 2026, for $260.00 per share, generating proceeds of $133,380. The transaction occurred while the share price sits close to its 52-week high. Separately, Standex reported fiscal 2026 second-quarter results that marginally outperformed expectations, and I…
Saba Capital Management, L.P., identified as a ten percent holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), sold 206,506 shares across February 26-27, 2026, for a combined $3,136,965. The transactions lowered the firm's reported holdings to 23,368,551 shares. ECAT is trading at $15.17, carries a market capitalization of $1.5 bil…
John D. Gottwald, a 10% owner of Tredegar Corporation (NYSE: TG), sold 16,822 shares across two transactions on February 26 and 27, 2026, for roughly $151,395. The trades occurred while Tredegar shares were trading close to their 52-week high and after a strong year-to-date gain. Separately, Tredegar’s Bonnell Aluminum unit announced an internal pr…
William M. Gottwald, who owns roughly ten percent of Tredegar Corp, executed two stock sales totaling 16,822 shares on February 26 and 27, 2026, for $151,395. The trades occurred as Tredegar's stock was trading near recent highs. Separately, Bonnell Aluminum, a Tredegar subsidiary, announced a leadership change with Tracy Bridges named Vice Preside…
James T. Gottwald, a roughly 10% owner of Tredegar Corp (TG), sold 16,823 shares across February 26 and 27, 2026, for a total of $151,404. The transactions were executed at prices between $8.87 and $9.09 per share. After the sales, Gottwald retains direct ownership of 40,000 shares and various indirect holdings. Separately, Bonnell Aluminum, a Tred…
